Chengyou Du

1.2k total citations
11 papers, 107 citations indexed

About

Chengyou Du is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chengyou Du has authored 11 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Chengyou Du's work include Pancreatic and Hepatic Oncology Research (8 papers), Gallbladder and Bile Duct Disorders (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Chengyou Du is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Gallbladder and Bile Duct Disorders (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Chengyou Du collaborates with scholars based in China and United States. Chengyou Du's co-authors include Jianguo Qiu, Ke Xu, Tingting Fu, Ming Li, Tao Ren, Ping He, Wei Tang, Bo Liu, Wei Zhou and Ping He and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

In The Last Decade

Chengyou Du

10 papers receiving 106 citations

Peers

Chengyou Du

ONCOL

PRM

SURGE

HEPAT

Mariaelena Casagrande Italy

Mario Domenico Rizzato Italy

Riccardo Memeo Italy

Valentina Zanuso Italy

Shuaixi Yang China

Baek‐Yeol Ryoo South Korea

Sherif Raouf United Kingdom

Yan-Fang Ye China

María Rodríguez–Soler Spain

Mariaelena Casagrande Italy

Chengyou Du

91 ×1.4

ONCOL

45 ×0.8

PRM

37 ×0.8

SURGE

19 ×0.7

HEPAT

15 ×0.9

Citations per year, relative to Chengyou Du Chengyou Du (= 1×) peers Mariaelena Casagrande

Countries citing papers authored by Chengyou Du

Since Specialization

Citations

This map shows the geographic impact of Chengyou Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyou Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyou Du more than expected).

Fields of papers citing papers by Chengyou Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyou Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyou Du. The network helps show where Chengyou Du may publish in the future.

Co-authorship network of co-authors of Chengyou Du

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyou Du. A scholar is included among the top collaborators of Chengyou Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyou Du. Chengyou Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Chen, Xiaolong, et al.. (2025). M2 macrophages and tumor cells engage in a metabolic feedback loop to drive HCC progression. Scientific Reports. 15(1). 41701–41701.

Wang, Jingwen, et al.. (2023). Digital single-operator cholangioscopy-guided endoluminal radiofrequency of an intraductal papillary mucinous neoplasia of the main pancreatic duct. Endoscopy. 55(S 01). E1079–E1080. 1 indexed citations

Tang, Wei, Yufei Zhao, Xufu Wei, et al.. (2022). Comparison of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic cancer: A systematic review and meta-analysis. International Journal of Surgery. 103. 106676–106676. 8 indexed citations

Tang, Wei, et al.. (2021). Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness. PLoS ONE. 16(3). e0248534–e0248534. 9 indexed citations

Liu, Bo, Tingting Fu, Ping He, et al.. (2021). GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. PeerJ. 9. e11423–e11423. 26 indexed citations

Tang, Wei, Jianguo Qiu, Guizhong Li, Yufei Zhao, & Chengyou Du. (2021). Clinical application of “Double R” anastomosis technique in laparoscopic pancreaticoduodenectomy procedure. Medicine. 100(21). e26204–e26204. 5 indexed citations

Cai, Yunshi, Bohan Zhang, Jiaxin Li, et al.. (2021). A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients. Frontiers in Oncology. 11. 711061–711061. 7 indexed citations

Liu, Bo, Tingting Fu, Ping He, Chengyou Du, & Ke Xu. (2021). Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer. Bioscience Reports. 41(7). 11 indexed citations

Qin, Shukui, Feng Bi, Jianming Xu, et al.. (2020). P-86 Comparison of the pharmacokinetics of donafenib and sorafenib in patients with advanced hepatocellular carcinoma: An open-label, randomized, parallel-controlled, multicentre phase II/III trial. Annals of Oncology. 31. S117–S118. 2 indexed citations

10.

Ren, Zhenggang, Jia Fan, Jian Xu, et al.. (2020). LBA2 Sintilimab plus bevacizumab biosimilar vs sorafenib as first-line treatment for advanced hepatocellular carcinoma (ORIENT-32)2. Annals of Oncology. 31. S1287–S1287. 25 indexed citations

11.

Qiu, Jianguo, Ming Li, & Chengyou Du. (2019). Antecolic reconstruction is associated with a lower incidence of delayed gastric emptying compared to retrocolic technique after Whipple or pylorus-preserving pancreaticoduodenectomy. Medicine. 98(34). e16663–e16663. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact